Activity of LY333328 in experimental meningitis caused by a Streptococcus pneumoniae strain susceptible to penicillin (Q39477892)

12 September 2017

Activity of LY333328 in experimental meningitis caused by a Streptococcus pneumoniae strain susceptible to penicillin (English)

1 reference

12 September 2017

1 reference

Streptococcus pneumoniae

1 reference

J Gerber

1

1 reference

12 September 2017

A Smirnov

2

1 reference

12 September 2017

A Wellmer

3

1 reference

12 September 2017

J Ragheb

4

1 reference

12 September 2017

J Prange

5

1 reference

12 September 2017

E Schütz

6

1 reference

12 September 2017

K Wettich

7

1 reference

12 September 2017

S Kalich

8

1 reference

12 September 2017

R Nau

9

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

Antimicrobial Agents and Chemotherapy

12 September 2017

1 reference

12 September 2017

45

1 reference

12 September 2017

7

1 reference

12 September 2017

2169-2172

1 reference

Achieving an optimal outcome in the treatment of infections. The role of clinical pharmacokinetics and pharmacodynamics of antimicrobials

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90624

Activity and diffusion of LY333328 in experimental endocarditis due to vancomycin-resistant Enterococcus faecalis

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90624

In vitro activity of the new glycopeptide LY333328 against multiply resistant gram-positive clinical isolates

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90624

Efficacy of LY333328 against experimental methicillin-resistant Staphylococcus aureus endocarditis

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90624

Differential release of lipoteichoic and teichoic acids from Streptococcus pneumoniae as a result of exposure to beta-lactam antibiotics, rifamycins, trovafloxacin, and quinupristin-dalfopristin

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90624

Comparative activities of LY 333328, a new glycopeptide, against penicillin-susceptible and -resistant pneumococci

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90624

Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90624

Surveillance of invasive Streptococcus pneumoniae infection in Quebec, Canada, from 1984 to 1986: serotype distribution, antimicrobial susceptibility, and clinical characteristics.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90624

Evaluation of vancomycin for therapy of adult pneumococcal meningitis

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90624

World-wide development of antibiotic resistance in pneumococci

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90624

Quinolone antibiotics in therapy of experimental pneumococcal meningitis in rabbits

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90624

A pneumococcal clinical isolate with high-level resistance to cefotaxime and ceftriaxone

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90624

Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90624

Quinupristin/dalfopristin attenuates the inflammatory response and reduces the concentration of neuron-specific enolase in the cerebrospinal fluid of rabbits with experimental Streptococcus pneumoniae meningitis

15 June 2018

1 reference

12 December 2020

Rifampin reduces early mortality in experimental Streptococcus pneumoniae meningitis

1 reference

12 December 2020

Lower lipoteichoic and teichoic acid CSF concentrations during treatment of pneumococcal meningitis with non-bacteriolytic antibiotics than with ceftriaxone

1 reference

12 December 2020

Antibacterial Activity of -Lactam Antibiotics in Experimental Meningitis Due to Streptococcus pneumoniae

1 reference

12 December 2020

Anti-inflammatory treatment influences neuronal apoptotic cell death in the dentate gyrus in experimental pneumococcal meningitis

1 reference

12 December 2020

Rifabutin for experimental pneumococcal meningitis

1 reference

12 December 2020

10.1128/AAC.45.7.2169-2172.2001

Identifiers

DOI

1 reference

12 September 2017

1 reference

12 September 2017

1 reference